GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

Q2 2024 GSK plc Earnings Call Transcript

Jul 31, 2024 / 11:00AM GMT
Release Date Price: $38.77 (-2.51%)
Nick Stone
GSK plc - Senior Vice President, Head of Investor Relations

Hello, everyone. Welcome to today's call and webcast. The presentation was sent to our distribution list by email today, and you can also find it on gsk.com. Please turn to Slide 2. This is the usual Safe Harbor statements will comment on our performance using constant exchange rates or CR, unless stated otherwise.

Please turn to slide 3. Today's call will last approximately one hour with the presentation taking around 35 minutes and the remaining time for your questions. Today, our speakers are all Emma Walmsley, Tony Woods, Luke Miels, Deborah Waterhouse, and Julie Brown with David Redfern joining for Q&A. Please ask one to two questions so that everyone has a chance to participate. Turning to Slide 4. I will now hand the call over to Emma.

Emma Walmsley
GSK plc - Chief Executive Officer, Executive Director

Welcome to everyone joining us today. Please turn to the next slide. I am delighted to report that GSK's momentum this year continues with excellent second quarter

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot